Exploring the mechanism of SLXG for treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking
The use of network pharmacology and molecular docking technology has revealed the mechanism of action of SLXG in NAFLD treatment, thus laying a theoretical foundation for the clinical application of SLXG in NAFLD therapy.
Authors
- Jia Liu (ORCID: https://orcid.org/0000-0002-5684-9594)
- Zitong Chen (ORCID: https://orcid.org/0000-0003-4069-1910)
- Wujie Wang (ORCID: https://orcid.org/0000-0001-9431-7153)
- Yang Wang (ORCID: https://orcid.org/0000-0003-0738-9621)
- Jiaxing Wang (ORCID: https://orcid.org/0000-0002-6674-4948)
- Yuliang Li (ORCID: https://orcid.org/0000-0001-8117-4317)
Institutions
- Shandong University (CN)
- Second Hospital of Shandong University (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1097/md.0000000000040255
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00